United Therapeutics (UTHR) Gross Margin (2009 - 2026)
United Therapeutics (UTHR) posted Gross Margin of 82.93% for Q1 2026, down 4.58% sequentially from 86.91% in Q4 2025, and down 543.0% YoY from 18.72% in Q1 2025.
United Therapeutics (UTHR) Gross Margin (2009 - 2026) Analysis & Trends
United Therapeutics has reported Gross Margin for 18 years, with the latest figure at 82.93% in Q1 2026.
- Quarterly Gross Margin fell 543.0% year-over-year to 82.93% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 86.58% (down 242.0% YoY) and the FY2025 annual result came in at 87.92%, down 131.0% from the prior year.
- Gross Margin slipped to 82.93% in Q1 2026 per UTHR's latest filing, from 86.91% in the prior quarter.
- Over five years, Gross Margin peaked at 94.39% in Q1 2022 and troughed at 82.93% in Q1 2026.
- A 5-year average of 89.19% and a median of 89.03% in 2025 frame the typical range for Gross Margin.
- The sharpest annual moves came in 2022 and 2026: Gross Margin surged 197 bps in 2022, then tumbled 543 bps in 2026.
- Over 5 years, Gross Margin stood at 88.04% in 2022, then grew by 0 bps to 88.45% in 2023, then gained by 1 bps to 89.69% in 2024, then slipped by 3 bps to 86.91% in 2025, then slipped by 5 bps to 82.93% in 2026.
- According to Business Quant data, Gross Margin over the past three periods registered 82.93%, 86.91%, and 87.38% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.01 Bn | 39.35 Bn | 2.15 Bn | 51.98% |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | 42.63% |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 66.66% |
| 5 | United Therapeutics | 22.17 Bn | 19.51 Bn | 683.80 Mn | 87.30% |
| 6 | Viatris | 18.73 Bn | 17.85 Bn | 1.46 Bn | 38.77% |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 97.58% |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 58.33% |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | - |
| 10 | Alkermes | 8.12 Bn | 7.46 Bn | 397.90 Mn | 80.22% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 87.30% |
| Mar 31, 2026 | 82.93% |
| Dec 31, 2025 | 86.91% |
| Sep 30, 2025 | 87.38% |
| Jun 30, 2025 | 89.03% |
| Mar 31, 2025 | 88.36% |
| Dec 31, 2024 | 89.69% |
| Sep 30, 2024 | 88.90% |
| Jun 30, 2024 | 89.12% |
| Mar 31, 2024 | 89.24% |
| Dec 31, 2023 | 88.45% |
| Sep 30, 2023 | 88.50% |
| Jun 30, 2023 | 89.25% |
| Mar 31, 2023 | 89.68% |
| Dec 31, 2022 | 88.04% |
| Sep 30, 2022 | 92.79% |
| Jun 30, 2022 | 93.64% |
| Mar 31, 2022 | 94.39% |
| Dec 31, 2021 | 91.67% |
| Sep 30, 2021 | 93.77% |